Global Bone Marrow Transplant Market Growth (Status and Outlook) 2023-2029

Global Bone Marrow Transplant Market Growth (Status and Outlook) 2023-2029

Bone marrow transplantation, also referred as hematopoietic stem cell transplantation is the process of replacing diseased or damaged bone marrow or bone marrow stem cells with healthy tissue. Bone marrow is a soft vascular tissue present in the interior of long bones, which is primarily responsible for hematopoiesis (formation of blood cells), production of lymphocytes, and storage of a fat. Bone marrow transplantation procedure is recommended to treat severe stages of leukemia, Hodgkin and non-Hodgkin lymphomas, multiple myeloma, aplastic and sickle cell anemia, thalassemia etc. 

LPI (LP Information)' newest research report, the “Bone Marrow Transplant Industry Forecast” looks at past sales and reviews total world Bone Marrow Transplant sales in 2022, providing a comprehensive analysis by region and market sector of projected Bone Marrow Transplant sales for 2023 through 2029. With Bone Marrow Transplant sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bone Marrow Transplant industry.

This Insight Report provides a comprehensive analysis of the global Bone Marrow Transplant landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bone Marrow Transplant portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bone Marrow Transplant market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bone Marrow Transplant and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bone Marrow Transplant.

The global Bone Marrow Transplant market size is projected to grow from US$ 8427.8 million in 2022 to US$ 9737.6 million in 2029; it is expected to grow at a CAGR of 2.1% from 2023 to 2029.

Increasing worldwide prevalence of cancers and anemia is the major driver for the growth of global bone marrow transplant market. Moreover, advances in technology, improving healthcare infrastructure, emerging indications of bone marrow transplant for heart and neuronal disorders, growing investment in logistic services, increasing per capita healthcare expenditure are some other factors expected to flourish the global bone marrow transplantation market. However, tremendous cost of the treatment, scarcity of bone marrow donors and uncertainty of reimbursement in several countries are some major restraints for the growth of global bone marrow transplantation market.

This report presents a comprehensive overview, market shares, and growth opportunities of Bone Marrow Transplant market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Autologous Bone Marrow Transplant
Allogeneic Bone marrow Transplant

Segmentation by application
Hospitals
Multispecialty Clinics
Ambulatory Surgical Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck Millipore Corporation
Sanofi-Aventis
AllCells
STEMCELL Technologies
ATCC
Hemacare Corporation
ReachBio
Conversant
PromoCell
Lifeline Cell Technology
Mesoblast

Please note: The report will take approximately 2 business days to prepare and deliver.